Also known as: LabSimply, Labsimply, Inc.
CRISPR powered Diagnostics with results in minutes.
Company is active
Event Year: 2021
Company is active
Event Year: 2021
VedaBio is revolutionizing diagnostic testing through the application of engineered CRISPR enzymes. Their syndromic testing approach aims to provide comprehensive and rapid results during routine doctor visits. By leveraging the power of CRISPR technology, VedaBio offers the potential for faster and more accurate diagnoses, leading to improved patient care and outcomes. Visit www.vedabio.com to learn more about their innovative solutions.
VedaBio is revolutionizing diagnostic testing through the application of engineered CRISPR enzymes. Their syndromic testing approach aims to provide comprehensive and rapid results during routine doctor visits. By leveraging the power of CRISPR technology, VedaBio offers the potential for faster and more accurate diagnoses, leading to improved patient care and outcomes. Visit www.vedabio.com to learn more about their innovative solutions.
Total Raised: Unknown (Y Combinator backed)
Last Round: Summer 2021
Total Raised: Unknown (Y Combinator backed)
Last Round: Summer 2021
Healthcare
Healthcare
Healthcare -> Diagnostics
Healthcare -> Diagnostics
Team size: 30
Hiring: No
Team size: 30
Hiring: No
